Back to Search
KYLE OHMAN, MD
MD
Emergency Medicine Physician
NPI: 1356072037Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
2022023028(MO)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
OTHER
Class of 2022
Research & Publications (20)
Percutaneous biopsy of cavernous sinus tumour via the foramen ovale.
PMID 19266151·Acta Neurochir (Wien)·2009
5-case
Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance.
PMID 17631296·Atherosclerosis·2008
4-observational
Development of a landfill model to prioritize design and operating objectives.
PMID 17492360·Environ Monit Assess·2007
8-other
Prospective, randomized trial of the effectiveness and retention of 30-min layperson training for cardiopulmonary resuscitation and automated external defibrillators: The American Airlines Study.
PMID 17452070·Resuscitation·2007
2-rct
Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPARalpha/gamma agonist, tesaglitazar.
PMID 17907107·Diab Vasc Dis Res·2007
2-rct
The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin.
PMID 17697874·Metabolism·2007
4-observational
Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial.
PMID 17166340·Curr Med Res Opin·2006
4-observational
Food does not affect the pharmacokinetics of tesaglitazar, a novel dual peroxisome proliferator-activated receptor alpha/gamma agonist.
PMID 16920896·J Clin Pharmacol·2006
2-rct
Subscores of the FAB differentiate frontotemporal lobar degeneration from AD.
PMID 16157906·Neurology·2005
8-other
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
PMID 15188945·Clin Cardiol·2004
3-trial
Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
PMID 15319332·Drug Metab Dispos·2004
3-trial
Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension.
PMID 15237695·Clin Cardiol·2004
3-trial
Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
PMID 15049387·Clin Cardiol·2004
3-trial
Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
PMID 14639093·J Cardiovasc Pharmacol·2003
3-trial
Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy.
PMID 13678427·BMC Cardiovasc Disord·2003
3-trial
B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
PMID 12640257·J Hypertens·2003
3-trial
Relationships between left ventricular mass and the renin-angiotensin system, catecholamines, insulin and leptin.
PMID 12528761·J Intern Med·2002
8-other
The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.
PMID 12359989·J Hypertens·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 HOSPITAL DR # DC029.10
COLUMBIA, MO 65212 - Phone
- (573) 884-3233
Quick Facts
- NPI
- 1356072037
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile